EL PASO, TX -- (Marketwired) -- 03/02/17 -- Premier Biomedical, Inc. (OTCQB: BIEI) announced today that the principal amounts on their outstanding convertible debts have been retired. The company acknowledged that, although it still needs capital to keep the business going, they will be more judicious in any future financing.
The company has in the past had as many as five lenders at once converting debt, as they struggled to finance their aggressive research programs on PTSD and cancer. T
RelSci News & Alerts gets you: